|1.||Lu, Weiyue: 2 articles (06/2012 - 04/2010)|
|2.||Zhan, Changyou: 2 articles (06/2012 - 04/2010)|
|3.||Tohme, Michel: 2 articles (08/2004 - 01/2004)|
|4.||Park, Ryan: 2 articles (08/2004 - 01/2004)|
|5.||Chen, Xiaoyuan: 2 articles (08/2004 - 01/2004)|
|6.||Bading, James R: 2 articles (08/2004 - 01/2004)|
|7.||Conti, Peter S: 2 articles (08/2004 - 01/2004)|
|8.||Zhu, Jing-Yi: 1 article (01/2016)|
|9.||Cheng, Si-Xue: 1 article (01/2016)|
|10.||Zhang, Xian-Zheng: 1 article (01/2016)|
08/01/2013 - "Among the cyclic peptide based integrin antagonists identified through both phage display and structure-activity studies, mainly αvβ3 integrin selective cyclic peptide c(RGDfK-) has found most widespread exploitations for targeting chemotherapeutic drugs/genes to both tumor and tumor vasculatures in anti-angiogenic cancer therapy. "
06/15/2011 - "In the present study, we synthesized novel trivalent lanthanide complexes containing the cyclic peptide c(RGDfK) to visualize the α(v)β(3)-integrin-expressing tumor cells. "
01/01/2016 - "Stimulated by the high content glutathione (GSH) in cytoplasm, the cleavage of disulfide bond resulted in the liberation of proapoptosis peptide C-KLA(TPP) and the p53 gene, which exerted the combined tumor therapy by regulating both intrinsic and extrinsic apoptotic pathways. "
02/01/2013 - "Furthermore, co-injection of (18)F-FP-AgRP-7C with a large molar excess of blocking peptide c(RGDyK) significantly inhibited tumor uptake in U87MG xenograft models, demonstrating the integrin-targeting specificity of the probe. "
07/01/2014 - "Compare with those of doxorubicin coupled DMP without peptide c(RGDyK) modification, D-DMP shows enhanced uptake by integrin alpha(v)beta3 targeting expressing tumor cells and displays stronger cancer cell cytotoxicity. "
|2.||Type 2 Diabetes Mellitus (MODY)
09/23/1989 - "[Insulin and peptide C secretion after food ingestion and the interaction of insulin with its erythrocyte receptor in a family with MODY type diabetes mellitus]."
06/01/2012 - "A study population consisting of 150 individuals was monitored after undergoing a MLSG, with individuals chosen based on a documented history of diabetes mellitus type 2 and metabolic syndrome, clinical results determining a body mass index (BMI) of 35 to 60 kg/m(2), peptide C level greater than 1, negative anti-glutamic acid decarboxylase, negative anti-insulin, and confirmed stability of drug/insulin treatment and glycosylated hemoglobin greater than 6.5% for at least 24 and 3 months, respectively, before enrollment. "
|3.||Wounds and Injuries (Trauma)
10/01/2013 - "In this study, we evaluated the wound healing properties of tailored laminin-332 α3 chain (peptide A: PPFLMLLKGSTR) tethered to a type I collagen scaffold using mTGase by incorporating transglutaminase substrate peptide sequences containing either glutamine (peptide B: PPFLMLLKGSTREAQQIVM) or lysine (peptide C: PPFLMLLKGSTRKKKKG) in rat full-thickness wound model at two different time points (7 and 21 days). "
|4.||Hypertension (High Blood Pressure)
08/01/2012 - "FINS, peptide C, HOMA-IR, and HOMA-islet were also higher in OSA patients with hypertension. "
08/01/1997 - "Atrial natriuretic peptide-C receptor and membrane signalling in hypertension."
03/01/2015 - "Anthropometric data, analytical data (insulin reserve, basal and postprandial peptide C, glycosylated hemoglobin, renal parameters, lipid profile and clinical data as hypertension, obesity, micro- and macrovascular complications were collected. "
01/01/2009 - "All the examined offspring's has had following examinations: BMJ, fasting glycaemia 2 times, OGTT, cholesterol, TG, HDL, LDL insulinaemia, peptide C, HbA1c, indirect insulin resistance index. "
03/01/2005 - "In the AL. vs. AT group, besides lower glucose level, lower concentrations of insulin (p<0.0001), peptide C (p<0.000001), as well as lower insulin secretion index (p<0.0001) and insulin resistance (HOMA) (p<0.001) were also observed. "
|3.||Glycosylated Hemoglobin A (Glycosylated Hemoglobin)
|4.||Collagen Type I (Type I Collagen)
|6.||Glutamate Decarboxylase (Decarboxylase, Glutamate)
|9.||cyclic arginine-glycine-aspartic acid peptide
|1.||Heterologous Transplantation (Xenotransplantation)